Lv5
1030 积分 2025-04-05 加入
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy
25天前
已完结
Metabolic control of innate-like T cells
1个月前
已完结
Oncolytic viruses and cytokine-based gene therapies reprogram the tumor microenvironment
1个月前
已完结
A guide to CAR T cell therapies: development, current status and future prospects
1个月前
已完结
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy
1个月前
已完结
Tumor microenvironment and metabolic reprogramming in MASLD-related hepatocellular carcinoma
2个月前
已完结
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy
2个月前
已完结
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
4个月前
已完结
CAR immune cells: design principles, resistance and the next generation
4个月前
已完结
Elements of cancer immunity and the cancer–immune set point
4个月前
已完结
皖公网安备34019202002308
